Cancer immunotherapy startup enters new chapter with SBIR support
Support from the National Science Foundation’s Small Business Innovation Research (SBIR) program is helping a Morgridge research team bring an important cancer immunotherapy technology to market. Learn more











































































































































































































































































































































